Israel: Myocarditis in young men may be related to Pfizer’s COVID-19 vaccine
- Global First: Bovine Avian Influenza Transmission to Humans Detected
- Potassium-Enriched Salt Substitutes: Reducing Blood Pressure Risk?
- Tritium Detection in Fukushima’s Seawater: Below Safety Standards
- What Reason Let AstraZeneca Withdraws COVID Vaccine From The Market?
- How Many Times Can a Cancer Patient Undergo Chemotherapy?
- What are the WHO recommendations for Japanese encephalitis vaccines?
Israel claims that myocarditis in some young men may be related to Pfizer’s COVID-19 vaccine
- AstraZeneca Admits for the First Time that its COVID Vaccine Has Blood Clot Side Effects
- Was COVID virus leaked from the Chinese WIV lab?
- HIV Cure Research: New Study Links Viral DNA Levels to Spontaneous Control
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Israel: Myocarditis in young men may be related to Pfizer’s COVID-19 vaccine. The Israeli Ministry of Health said late on Tuesday that some young men developed heart inflammation after the second dose of Pfizer -BioNTech SE COVID-19 vaccine. Ministry of Health officials discovered that this may be related to the vaccination.
More than 5 million people in Israel have been vaccinated with this vaccine, and the number of COVID-19 cases has dropped significantly. The Israeli Ministry of Health said on Wednesday that despite the above-mentioned association, it will expand the use of Pfizer’s vaccine to people aged 12-16 years. Earlier, the US Food and Drug Administration approved the authorization for use in this age group.
According to an investigation conducted by officials of the Israeli Ministry of Health, between the start of the vaccine program in December 2020 and May 2021, 275 cases of myocarditis occurred, of which 148 cases occurred within one month after vaccination. Among them, 27 cases appeared after the first dose of vaccination, and 121 cases appeared after the second dose of vaccination; about half of the patients had underlying diseases.
Pfizer said in a statement that currently, there is still no evidence that these cases were caused by vaccination. The company said that myocarditis is generally caused by a viral infection, and there have been reports that infection with the new coronavirus can cause this condition. BioNTech responded that more than 300 million doses of Pfizer/BioNTech’s COVID-19 vaccine have been vaccinated globally, and the benefits of the vaccine outweigh the risks.
“The report is being carefully evaluated and no conclusions have been reached yet,” the company pointed out. “The company and regulatory authorities continue to regularly and thoroughly evaluate side effects including myocarditis and pericarditis.”
At 9:51 New York time, Pfizer rose 1% to $38.89, and BioNTech’s ADR rose 0.4% to $169.65.
The Israeli health department stated that most of the cases were young men, especially those aged 16-19. In most cases, patients are admitted to the hospital for treatment for no more than four days, and 95% of the cases are classified as mild.
“The risk of contracting the new coronavirus is greater than the risk of vaccination,” said the country’s Ministry of Health. The number of patients with myocarditis is very small, and in most cases, patients can fully recover.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
